Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
Magnetic Resonance Imaging|January 1, 1997
Magnetic resonance renography: optimisation of pulse sequence parameters and Gd-DTPA dose, and comparison with radionuclide renographyJ Taylor, P E Summers, S F Keevil, et al.Plos Genetics|August 29, 2007
Assessing the significance of conserved genomic aberrations using high resolution genomic microarraysMitchell Guttman, Carolyn Mies, Katarzyna Dudycz-Sulicz, et al.Nucleic Acids Research|September 12, 2008
Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platformsSharon J Diskin, Mingyao Li, Cuiping Hou, et al.Nephron|March 13, 1998
Edema, oncotic pressure, and free entropy: novel considerations for the treatment of edema through attention to thermodynamicsC J Diskin, R B Gupta, W Ravis, et al.Molecular Cancer Research : MCR|May 29, 2008
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor geneKristina A Cole, Edward F Attiyeh, Yael P Mosse, et al.International Journal of Cancer|September 6, 2012
Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibitionPatrick A Mayes, Yan Y Degenhardt, Andrew Wood, et al.Journal of Cellular and Molecular Medicine|July 2, 2017
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastomaMario Capasso, Lee D McDaniel, Flora Cimmino, et al.American Journal of Human Genetics|September 3, 2019
Germline 16p11.2 Microdeletion Predisposes to NeuroblastomaLaura E Egolf, Zalman Vaksman, Gonzalo Lopez, et al.Biorxiv : the Preprint Server for Biology|June 19, 2024
IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.Journal of the National Cancer Institute|February 23, 2019
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal NeuroblastomaDerek A Oldridge, Bao Truong, Douglas Russ, et al.Pageof 14